Hopes Mount On Sun's 'Game Changer' Psoriasis Asset

Sun Pharmaceutical Industries Ltd.'s late-stage psoriasis asset has met its primary endpoints in two pivotal studies, setting the stage for increased competition in a crowded and high stakes segment.